loader
Please Wait
Applying Filters...

Looking for Pharmaceutical Excipients offered by Nanjing Well Pharmaceutical? Find Monophosphoryl Lipid A / MPLA to address your drug delivery challenges on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Injectable / Parenteral

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral

Nanjing Well Pharmaceutical

Excipient Details : MPLA is a highly specific TLR4 agonist that activates the innate immune response, induces the production of cytokines, and activate specific T cells.

Pharmacopoeia Ref : NA

Technical Specs : Water content, microbial limits, residual solvents meet the requirements for vaccine use; Sealed & stored at -20 degree Celsius

Grade : Parenteral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Ingredient(s) : Monophosphoryl Lipid A

Dosage Form : Injectable / Parenteral

Category : Parenteral

Brand : MPLA

Applications : MPLA is a highly specific TLR4 agonist that activates the innate immune response, induces the production of cytokines, and activate specific T cells.

Pharmacopoeia Ref : NA

Technical Specs : Water content, microbial limits, residual solvents meet the requirements for vaccine use; Sealed & stored at -20 degree Celsius

Grade : Parenteral

arrow